A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception

Neuroscience

Volumn 175, Issue , 2011, Pages 315-327

  Hall, F S ^a   Schwarzbaum, J M ^a   Perona, M T G ^a   Templin, J S ^a   Caron, M G ^b   Lesch, K P ^c   Murphy, D L ^d   Uhl, G R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Amitriptyline; Analgesia; Knockout mice; Nociception; Norepinephrine transporter; Serotonin transporter

Indexed keywords

AMITRIPTYLINE; FLUOXETINE; MORPHINE; NISOXETINE; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENOTYPE; HYPOALGESIA; KNOCKOUT MOUSE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; THERMAL EXPOSURE;

ANALGESIA; ANIMALS; FEMALE; HYPERALGESIA; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURONS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 78951490152     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.11.057     Document Type: Article

References (95)

1. Abdi S., Lee D.H., Chung J.M. The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth Analg 1998, 87(6):1360-1366.
2. Acton J., McKenna J.E., Melzack R. Amitriptyline produces analgesia in the formalin pain test. Exp Neurol 1992, 117(1):94-96.
3. Aimone L.D., Jones S.L., Gebhart G.F. Stimulation-produced descending inhibition from the periaqueductal gray and nucleus raphe magnus in the rat: mediation by spinal monoamines but not opioids. Pain 1987, 31(1):123-136.
4. Ardid D., Eschalier A., Lavarenne J. Evidence for a central but not a peripheral analgesic effect of clomipramine in rats. Pain 1991, 45(1):95-100.
5. Ardid D., Jourdan D., Mestre C., Villanueva L., Le Bars D., Eschalier A. Involvement of bulbospinal pathways in the antinociceptive effect of clomipramine in the rat. Brain Res 1995, 695(2):253-256.
6. Ardid D., Marty H., Fialip J., Privat A.M., Eschalier A., Lavarenne J. Comparative effects of different uptake inhibitor antidepressants in two pain tests in mice. Fundam Clin Pharmacol 1992, 6(2):75-82.
7. Arts K.S., Holmes B.B., Fujimoto J.M. Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-D-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice. J Pharmacol Exp Ther 1991, 256(3):890-896.
8. Baker A., Klimscha W., Eisenach J.C., Li X.H., Wildling E., Menth-Chiari W.A., Chiari A.I. Intrathecal clonidine for postoperative analgesia in elderly patients: the influence of baricity on hemodynamic and analgesic effects. Anesth Analg 2004, 99(1):128-134.
9. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., Mossner R., Westphal H., Lesch K.P. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 1998, 53(4):649-655.
10. Bie B., Fields H.L., Williams J.T., Pan Z.Z. Roles of alpha1- and alpha2-adrenoceptors in the nucleus raphe magnus in opioid analgesia and opioid abstinence-induced hyperalgesia. J Neurosci 2003, 23(21):7950-7957.
11. Bohn L.M., Xu F., Gainetdinov R.R., Caron M.G. Potentiated opioid analgesia in norepinephrine transporter knock-out mice. J Neurosci 2000, 20(24):9040-9045.
12. Botney M., Fields H.L. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol 1983, 13(2):160-164.
13. Buerkle H., Yaksh T.L. Pharmacological evidence for different alpha 2-adrenergic receptor sites mediating analgesia and sedation in the rat. Br J Anaesth 1998, 81(2):208-215.
14. Carter G.T., Sullivan M.D. Antidepressants in pain management. Curr Opin Investig Drugs 2002, 3(3):454-458.
15. Chiari A., Lorber C., Eisenach J.C., Wildling E., Krenn C., Zavrsky A., Kainz C., Germann P., Klimscha W. Analgesic and hemodynamic effects of intrathecal clonidine as the sole analgesic agent during first stage of labor: a dose-response study. Anesthesiology 1999, 91(2):388-396.
16. Cui M., Feng Y., McAdoo D.J., Willis W.D. Periaqueductal gray stimulation-induced inhibition of nociceptive dorsal horn neurons in rats is associated with the release of norepinephrine, serotonin, and amino acids. J Pharmacol Exp Ther 1999, 289(2):868-876.
17. Davis K.D., Treede R.D., Raja S.N., Meyer R.A., Campbell J.N. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 1991, 47(3):309-317.
18. De Kock M., Wiederkher P., Laghmiche A., Scholtes J.L. Epidural clonidine used as the sole analgesic agent during and after abdominal surgery. A dose-response study. Anesthesiology 1997, 86(2):285-292.
19. Egbunike I.G., Chaffee B.J. Antidepressants in the management of chronic pain syndromes. Pharmacotherapy 1990, 10(4):262-270.
20. Eide K., Hole K. Interactions between substance P and norepinephrine in the regulation of nociception in mouse spinal cord. Pharmacol Toxicol 1992, 70(6 Pt 1):397-401.
21. Eisenach J.C. Three novel spinal analgesics: clonidine, neostigmine, amitriptyline. Reg Anesth 1996, 21(Suppl 6):81-83.
22. Eisenach J.C., Gebhart G.F. Intrathecal amitriptyline. Antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine, and carbamylcholine in rats. Anesthesiology 1995, 83(5):1036-1045.
23. Eisenach J.C., Gebhart G.F. Intrathecal amitriptyline acts as an N-methyl-d-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats. Anesthesiology 1995, 83(5):1046-1054.
24. Eisenach J.C., Hood D.D., Curry R. Intrathecal, but not intravenous, clonidine reduces experimental thermal or capsaicin-induced pain and hyperalgesia in normal volunteers. Anesth Analg 1998, 87(3):591-596.
25. Elmer G.I., Evans J.L., Ladenheim B., Epstein C.J., Cadet J.L. Transgenic superoxide dismutase mice differ in opioid-induced analgesia. Eur J Pharmacol 1995, 283(1-3):227-232.
26. Esser M.J., Chase T., Allen G.V., Sawynok J. Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions. Eur J Pharmacol 2001, 430(2-3):211-218.
27. Esser M.J., Sawynok J. Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects. Pain 1999, 80(3):643-653.
28. Esser M.J., Sawynok J. Caffeine blockade of the thermal antihyperalgesic effect of acute amitriptyline in a rat model of neuropathic pain. Eur J Pharmacol 2000, 399(2-3):131-139.
29. Frank R.G., Kashani J.H., Parker J.C., Beck N.C., Brownlee-Duffeck M., Elliott T.R., Haut A.E., Atwood C., Smith E., Kay D.R. Antidepressant analgesia in rheumatoid arthritis. J Rheumatol 1988, 15(11):1632-1638.
30. Galeotti N., Ghelardini C., Bartolini A. Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. Eur J Pharmacol 1996, 308(2):125-133.
31. Galeotti N., Ghelardini C., Bartolini A. Involvement of potassium channels in amitriptyline and clomipramine analgesia. Neuropharmacology 2001, 40(1):75-84.
32. Gatch M.B., Negus S.S., Mello N.K. Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys. Psychopharmacology (Berl) 1998, 135(1):99-106.
33. Gerner P., Kao G., Srinivasa V., Narang S., Wang G.K. Topical amitriptyline in healthy volunteers. Reg Anesth Pain Med 2003, 28(4):289-293.
34. Ghelardini C., Galeotti N., Bartolini A. Amitriptyline and clomipramine activate Gi-protein signaling pathway in the induction of analgesia. Naunyn Schmiedebergs Arch Pharmacol 2002, 365(1):1-7.
35. Gordon N.C., Heller P.H., Gear R.W., Levine J.D. Temporal factors in the enhancement of morphine analgesia by desipramine. Pain 1993, 53(3):273-276.
36. Gordon N.C., Heller P.H., Gear R.W., Levine J.D. Interactions between fluoxetine and opiate analgesia for postoperative dental pain. Pain 1994, 58(1):85-88.
37. Hall F.S., Li X.F., Sora I., Xu F., Caron M., Lesch K.P., Murphy D.L., Uhl G.R. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience 2002, 115(1):153-161.
38. Hamon M., Gozlan H., Bourgoin S., Benoliel J.J., Mauborgne A., Taquet H., Cesselin F., Mico J.A. Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline. Neuropharmacology 1987, 26(6):531-539.
39. Hersh E.V., Kaplan P. Antinociceptive action of tricyclic antidepressant drugs in the rat. Anesth Prog 1990, 37(4):186-189.
40. Heughan C.E., Sawynok J. The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration. Anesth Analg 2002, 94(4):975-980. table of contents.
41. Hwang A.S., Wilcox G.L. Analgesic properties of intrathecally administered heterocyclic antidepressants. Pain 1987, 28(3):343-355.
42. Jasmin L., Tien D., Weinshenker D., Palmiter R.D., Green P.G., Janni G., Ohara P.T. The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline. Proc Natl Acad Sci U S A 2002, 99(2):1029-1034.
43. Jensen T.S., Yaksh T.L. Examination of spinal monoamine receptors through which brainstem opiate-sensitive systems act in the rat. Brain Res 1986, 363(1):114-127.
44. Jensen T.S., Yaksh T.L. Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat. Brain Res 1986, 363(1):99-113.
45. Jensen T.S., Yaksh T.L. Comparison of the antinociceptive action of mu and delta Opioid receptor ligands in the periaqueductal gray matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique. Brain Res 1986, 372(2):301-312.
46. Khan M.A., Gerner P., Kuo Wang G. Amitriptyline for prolonged cutaneous analgesia in the rat. Anesthesiology 2002, 96(1):109-116.
47. Korzeniewska-Rybicka I., Plaznik A. Supraspinally mediated analgesic effect of antidepressant drugs. Pol J Pharmacol 2000, 52(2):93-99.
48. Levine J.D., Gordon N.C., Smith R., McBryde R. Desipramine enhances opiate postoperative analgesia. Pain 1986, 27(1):45-49.
49. Lipp J. Possible mechanisms of morphine analgesia. Clin Neuropharmacol 1991, 14(2):131-147.
50. Liu S.J., Wang R.I. Increased sensitivity of the central nervous system to morphine analgesia by amitriptyline in naive and morphine-tolerant rats. Biochem Pharmacol 1981, 30(15):2103-2109.
51. Luccarini P., Perrier L., Degoulange C., Gaydier A.M., Dallel R. Synergistic antinociceptive effect of amitriptyline and morphine in the rat orofacial formalin test. Anesthesiology 2004, 100(3):690-696.
52. Malseed R.T., Goldstein F.J. Enhancement of morphine analgesia by tricyclic antidepressants. Neuropharmacology 1979, 18(10):827-829.
53. Mathews T.A., Fedele D.E., Coppelli F.M., Avila A.M., Murphy D.L., Andrews A.M. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods 2004, 140(1-2):169-181.
54. Max M.B., Culnane M., Schafer S.C., Gracely R.H., Walther D.J., Smoller B., Dubner R. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987, 37(4):589-596.
55. Mogil J.S., Wilson S.G. Nociceptive and morphine antinociceptive sensitivity of 129 and C57BL/6 inbred mouse strains: implications for transgenic knock-out studies. Eur J Pain 1997, 1(4):293-297.
56. Mogil J.S., Wilson S.G., Bon K., Lee S.E., Chung K., Raber P., Pieper J.O., Hain H.S., Belknap J.K., Hubert L., Elmer G.I., Chung J.M., Devor M. Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain 1999, 80(1-2):67-82.
57. Naguib M., Yaksh T.L. Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems. Anesthesiology 1994, 80(6):1338-1348.
58. Nicolodi M., Sicuteri F. Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy. Adv Exp Med Biol 1996, 398:373-379.
59. Oatway M., Reid A., Sawynok J. Peripheral antihyperalgesic and analgesic actions of ketamine and amitriptyline in a model of mild thermal injury in the rat. Anesth Analg 2003, 97(1):168-173. table of contents.
60. Onghena P., Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992, 49(2):205-219.
61. Pan H.L., Chen S.R., Eisenach J.C. Intrathecal clonidine alleviates allodynia in neuropathic rats: interaction with spinal muscarinic and nicotinic receptors. Anesthesiology 1999, 90(2):509-514.
62. Pancrazio J.J., Kamatchi G.L., Roscoe A.K., Lynch C. Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther 1998, 284(1):208-214.
63. Pasternak G.W., Gintzler A.R., Houghten R.A., Ling G.S., Goodman R.R., Spiegel K., Nishimura S., Johnson N., Recht L.D. Biochemical and pharmacological evidence for opioid receptor multiplicity in the central nervous system. Life Sci 1983, 33(Suppl 1):167-173.
64. Perona M.T., Waters S., Hall F.S., Sora I., Lesch K.P., Murphy D.L., Caron M., Uhl G.R. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav Pharmacol 2008, 19(5-6):566-574.
65. Ren-Patterson R.F., Cochran L.W., Holmes A., Sherrill S., Huang S.J., Tolliver T., Lesch K.P., Lu B., Murphy D.L. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res 2005, 79(6):756-771.
66. Richeimer S.H., Bajwa Z.H., Kahraman S.S., Ransil B.J., Warfield C.A. Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey. Clin J Pain 1997, 13(4):324-329.
67. Rigal F., Eschalier A., Devoize J.L., Pechadre J.C. Activities of five antidepressants in a behavioral pain test in rats. Life Sci 1983, 32(26):2965-2971.
68. Sacerdote P., Brini A., Mantegazza P., Panerai A.E. A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmacol Biochem Behav 1987, 26(1):153-158.
69. Sawynok J., Esser M.J., Reid A.R. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 1999, 82(2):149-158.
70. Sawynok J., Esser M.J., Reid A.R. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001, 26(1):21-29.
71. Sawynok J., Reid A. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia. Brain Res 1987, 419(1-2):156-165.
72. Sawynok J., Reid A. Lesions to ascending noradrenergic and serotonergic pathways modify antinociception produced by intracerebroventricular administration of morphine. Neuropharmacology 1989, 28(2):141-147.
73. Sawynok J., Reid A. Desipramine potentiates spinal antinociception by 5-hydroxytryptamine, morphine and adenosine. Pain 1992, 50(1):113-118.
74. Sawynok J., Reid A. Antinociception by tricyclic antidepressants in the rat formalin test: differential effects on different behaviors following systemic and spinal administration. Pain 2001, 93(1):51-59.
75. Sawynok J., Reid A.R., Esser M.J. Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine. Pain 1999, 80(1-2):45-55.
76. Shen H.W., Hagino Y., Kobayashi H., Shinohara-Tanaka K., Ikeda K., Yamamoto H., Yamamoto T., Lesch K.P., Murphy D.L., Hall F.S., Uhl G.R., Sora I. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 2004, 29(10):1790-1799.
77. Siddall P.J., Polson J.W., Dampney R.A. Descending antinociceptive pathway from the rostral ventrolateral medulla: a correlative anatomical and physiological study. Brain Res 1994, 645(1-2):61-68.
78. Sora I., Elmer G., Funada M., Pieper J., Li X.F., Hall F.S., Uhl G.R. Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve. Neuropsychopharmacology 2001, 25(1):41-54.
79. Sora I., Hall F.S., Andrews A.M., Itokawa M., Li X.F., Wei H.B., Wichems C., Lesch K.P., Murphy D.L., Uhl G.R. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci U S A 2001, 98(9):5300-5305.
80. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., Uhl G.R. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci U S A 1998, 95(13):7699-7704.
81. Spiegel K., Kalb R., Pasternak G.W. Analgesic activity of tricyclic antidepressants. Ann Neurol 1983, 13(4):462-465.
82. Sudoh Y., Desai S.P., Haderer A.E., Sudoh S., Gerner P., Anthony D.C., De Girolami U., Wang G.K. Neurologic and histopathologic evaluation after high-volume intrathecal amitriptyline. Reg Anesth Pain Med 2004, 29(5):434-440.
83. Taiwo Y.O., Fabian A., Pazoles C.J., Fields H.L. Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord. Pain 1985, 21(4):329-337.
84. Tura B., Tura S.M. The analgesic effect of tricyclic antidepressants. Brain Res 1990, 518(1-2):19-22.
85. Ventafridda V., Bianchi M., Ripamonti C., Sacerdote P., De Conno F., Zecca E., Panerai A.E. Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man. Pain 1990, 43(2):155-162.
86. Vogel C., Mossner R., Gerlach M., Heinemann T., Murphy D.L., Riederer P., Lesch K.P., Sommer C. Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neurosci 2003, 23(2):708-715.
87. Watson C.P. Therapeutic window for amitriptyline analgesia. Can Med Assoc J 1984, 130(2):105-106.
88. Watson C.P., Chipman M., Reed K., Evans R.J., Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992, 48(1):29-36.
89. Wigdor S., Wilcox G.L. Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. J Pharmacol Exp Ther 1987, 242(1):90-95.
90. Xu F., Gainetdinov R.R., Wetsel W.C., Jones S.R., Bohn L.M., Miller G.W., Wang Y.M., Caron M.G. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 2000, 3(5):465-471.
91. Yaksh T.L. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res 1979, 160(1):180-185.
92. Yaksh T.L., Tyce G.M. Microinjection of morphine into the periaqueductal gray evokes the release of serotonin from spinal cord. Brain Res 1979, 171(1):176-181.
93. Yeomans D.C., Clark F.M., Paice J.A., Proudfit H.K. Antinociception induced by electrical stimulation of spinally projecting noradrenergic neurons in the A7 catecholamine cell group of the rat. Pain 1992, 48(3):449-461.
94. Young R.J., Clarke B.F. Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs. Diabet Med 1985, 2(5):363-366.
95. Zhong F.X., Ji X.Q., Tsou K. Intrathecal DSP4 selectively depletes spinal noradrenaline and attenuates morphine analgesia. Eur J Pharmacol 1985, 116(3):327-330.